Bond Johnson & Johnson Inc. 6.95% ( US478160AJ37 ) in USD

Issuer	Johnson & Johnson Inc.
Market price	109.42 % ▼
Country	United States
ISIN code	US478160AJ37 ( in USD )
Interest rate	6.95% per year ( payment 2 times a year)
Maturity	01/09/2029
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible
Minimal amount	1 000 USD
Total amount	300 000 000 USD
Cusip	478160AJ3
Standard & Poor's ( S&P ) rating	AAA ( Prime - Investment-grade )
Moody's rating	Aaa ( Prime - Investment-grade )
Next Coupon	01/09/2026 ( In 148 days )
Detailed description	Johnson & Johnson is a multinational corporation that manufactures and sells a wide range of healthcare products, including pharmaceuticals, medical devices, and consumer health products. This financial article provides a comprehensive overview of a specific bond issuance by Johnson & Johnson, a globally renowned healthcare giant, offering investors a detailed look at its key characteristics and the underlying strength of its issuer. Johnson & Johnson, headquartered in the United States, stands as one of the world's most comprehensive and broadly based healthcare companies. With a rich history spanning over 135 years, the company is deeply engaged in the research and development, manufacturing, and sale of a wide range of products in the pharmaceutical, medical devices, and consumer health sectors. Its diverse portfolio includes well-known brands and innovative treatments, contributing to its robust revenue streams and strong financial position. The company's exceptional creditworthiness is underscored by its top-tier ratings from leading global agencies: AAA by Standard & Poor's (S&P) and Aaa by Moody's, reflecting an extremely strong capacity to meet its financial commitments, indicating minimal credit risk. The bond in question, identified by ISIN US478160AJ37 and CUSIP 478160AJ3, is an obligation issued by Johnson & Johnson from its home country, the United States. This debt instrument carries an attractive annual interest rate of 6.95%, payable semi-annually (frequency of 2). The bond is currently trading at par, priced at 100% of its face value, denominated in U.S. Dollars (USD). The total size of this particular issue amounts to $300,000,000, with a minimum investment threshold set at $1,000, making it accessible to a range of institutional and individual investors. The maturity date for this bond is September 1, 2029, providing a clear timeframe for investors to receive their principal back. The dual AAA/Aaa credit ratings assigned by Standard & Poor's and Moody's, respectively, are the highest possible ratings awarded by these agencies. For investors, these ratings signify that Johnson & Johnson possesses an exceptional ability to repay its debt obligations, indicating a very low risk of default. Combined with a significant coupon rate of 6.95% in the current market environment, this bond represents a compelling opportunity for investors seeking yield from a highly stable and creditworthy corporate issuer. Its par trading price further suggests market confidence in the issuer and the terms of the offering.